One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v130.suppl_1.2633.2633
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
Affiliation: Vanderbilt University, Memorial Sloan Kettering Cancer Center, University of Michigan–Ann Arbor, Duke University, Columbia University Irving Medical Center, University of Iowa, Oregon Health & Science University, Cleveland Clinic, Columbia University, Duke Medical Center, The University of Texas MD Anderson Cancer Center, Cornell University, Dana-Farber Cancer Institute, University of PittsburghEarly Results from a Biomarker-Directed Phase 2 Trial of Sy-1425 in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Demonstrate DHRS3 Induction and Myeloid Differentiation Following Sy-1425 Treatment
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
